[Management of brain metastases from non-small cell lung carcinoma].
In France, approximately 30,000 new patients per year develop brain metastases (BM), most of them resulting from a lung cancer. Surgery and radiosurgery of all the BM must be considered when possible. In other cases, whole brain radiotherapy remains the standard of care. The role of chemotherapy, poorly investigated so far, should be revisited. This review focused on BM secondary to a non-small cell lung carcinoma.